On July 5, 2025, NewGenIvf Group Ltd.'s Board of Directors approved a reverse stock split, consolidating all issued and unissued shares, including Class A and Class B ordinary shares and preferred shares, at a ratio of one share for every five shares. This move, which does not require shareholder approval, aims to adjust the number of shares without altering their par value. No fractional shares will be issued; instead, shareholders will receive one full share for any fractional entitlements.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.